nodes	percent_of_prediction	percent_of_DWPC	metapath
Spironolactone—ABCB1—melanoma	0.456	1	CbGaD
Spironolactone—ABCC2—Docetaxel—melanoma	0.0255	0.511	CbGbCtD
Spironolactone—ABCB1—Dactinomycin—melanoma	0.0161	0.323	CbGbCtD
Spironolactone—Carcinoma breast—Docetaxel—melanoma	0.0143	0.0731	CcSEcCtD
Spironolactone—ABCB1—Docetaxel—melanoma	0.00831	0.167	CbGbCtD
Spironolactone—Vasculitis—Vemurafenib—melanoma	0.00585	0.0298	CcSEcCtD
Spironolactone—Drug fever—Docetaxel—melanoma	0.00582	0.0296	CcSEcCtD
Spironolactone—Breast cancer—Docetaxel—melanoma	0.00532	0.0271	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.00373	0.019	CcSEcCtD
Spironolactone—Ulcer—Bleomycin—melanoma	0.00366	0.0186	CcSEcCtD
Spironolactone—Eosinophilia—Vemurafenib—melanoma	0.00355	0.0181	CcSEcCtD
Spironolactone—Menstruation irregular—Docetaxel—melanoma	0.00351	0.0179	CcSEcCtD
Spironolactone—Ulcer—Dactinomycin—melanoma	0.00341	0.0174	CcSEcCtD
Spironolactone—Breast pain—Temozolomide—melanoma	0.00335	0.017	CcSEcCtD
Spironolactone—Amenorrhoea—Temozolomide—melanoma	0.00332	0.0169	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00317	0.0161	CcSEcCtD
Spironolactone—Erythema multiforme—Vemurafenib—melanoma	0.00271	0.0138	CcSEcCtD
Spironolactone—Gynaecomastia—Carmustine—melanoma	0.0027	0.0138	CcSEcCtD
Spironolactone—Rash erythematous—Docetaxel—melanoma	0.00254	0.0129	CcSEcCtD
Spironolactone—Alopecia—Vemurafenib—melanoma	0.00253	0.0129	CcSEcCtD
Spironolactone—Lethargy—Dactinomycin—melanoma	0.00239	0.0122	CcSEcCtD
Spironolactone—Amenorrhoea—Docetaxel—melanoma	0.00221	0.0113	CcSEcCtD
Spironolactone—Testosterone Propionate—CYP17A1—melanoma	0.0022	0.316	CrCbGaD
Spironolactone—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.00211	0.0107	CcSEcCtD
Spironolactone—Ataxia—Carmustine—melanoma	0.00206	0.0105	CcSEcCtD
Spironolactone—Anaphylactic shock—Vemurafenib—melanoma	0.00204	0.0104	CcSEcCtD
Spironolactone—Ataxia—Temozolomide—melanoma	0.00199	0.0101	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Temozolomide—melanoma	0.00191	0.00972	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.00179	0.00912	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Vemurafenib—melanoma	0.00176	0.00896	CcSEcCtD
Spironolactone—Erectile dysfunction—Temozolomide—melanoma	0.00169	0.00859	CcSEcCtD
Spironolactone—Agranulocytosis—Dactinomycin—melanoma	0.00168	0.00858	CcSEcCtD
Spironolactone—Renal failure—Carmustine—melanoma	0.00166	0.00846	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00162	0.00825	CcSEcCtD
Spironolactone—Body temperature increased—Vemurafenib—melanoma	0.00161	0.00821	CcSEcCtD
Spironolactone—Alopecia—Bleomycin—melanoma	0.00154	0.00782	CcSEcCtD
Spironolactone—Erythema multiforme—Dactinomycin—melanoma	0.00153	0.00781	CcSEcCtD
Spironolactone—Hypersensitivity—Vemurafenib—melanoma	0.0015	0.00765	CcSEcCtD
Spironolactone—Pruritus—Vemurafenib—melanoma	0.00144	0.00734	CcSEcCtD
Spironolactone—Lethargy—Docetaxel—melanoma	0.00144	0.00733	CcSEcCtD
Spironolactone—Alopecia—Dactinomycin—melanoma	0.00143	0.0073	CcSEcCtD
Spironolactone—Ill-defined disorder—Bleomycin—melanoma	0.0014	0.00715	CcSEcCtD
Spironolactone—Diarrhoea—Vemurafenib—melanoma	0.00139	0.0071	CcSEcCtD
Spironolactone—Erythema multiforme—Temozolomide—melanoma	0.00139	0.00706	CcSEcCtD
Spironolactone—Malaise—Bleomycin—melanoma	0.00136	0.00695	CcSEcCtD
Spironolactone—Leukopenia—Bleomycin—melanoma	0.00135	0.0069	CcSEcCtD
Spironolactone—Dizziness—Vemurafenib—melanoma	0.00135	0.00686	CcSEcCtD
Spironolactone—Alopecia—Carmustine—melanoma	0.00134	0.00683	CcSEcCtD
Spironolactone—Ataxia—Docetaxel—melanoma	0.00133	0.00675	CcSEcCtD
Spironolactone—Ill-defined disorder—Dactinomycin—melanoma	0.00131	0.00667	CcSEcCtD
Spironolactone—Vomiting—Vemurafenib—melanoma	0.0013	0.0066	CcSEcCtD
Spironolactone—Alopecia—Temozolomide—melanoma	0.0013	0.0066	CcSEcCtD
Spironolactone—Rash—Vemurafenib—melanoma	0.00128	0.00655	CcSEcCtD
Spironolactone—Dermatitis—Vemurafenib—melanoma	0.00128	0.00654	CcSEcCtD
Spironolactone—Headache—Vemurafenib—melanoma	0.00128	0.0065	CcSEcCtD
Spironolactone—Discomfort—Bleomycin—melanoma	0.00127	0.00648	CcSEcCtD
Spironolactone—Malaise—Dactinomycin—melanoma	0.00127	0.00648	CcSEcCtD
Spironolactone—Cramp muscle—Docetaxel—melanoma	0.00127	0.00646	CcSEcCtD
Spironolactone—Toxic epidermal necrolysis—Docetaxel—melanoma	0.00127	0.00646	CcSEcCtD
Spironolactone—Leukopenia—Dactinomycin—melanoma	0.00126	0.00643	CcSEcCtD
Spironolactone—Confusional state—Bleomycin—melanoma	0.00124	0.00634	CcSEcCtD
Spironolactone—Anaphylactic shock—Bleomycin—melanoma	0.00123	0.00629	CcSEcCtD
Spironolactone—Nausea—Vemurafenib—melanoma	0.00121	0.00617	CcSEcCtD
Spironolactone—Thrombocytopenia—Bleomycin—melanoma	0.00121	0.00616	CcSEcCtD
Spironolactone—Discomfort—Dactinomycin—melanoma	0.00119	0.00605	CcSEcCtD
Spironolactone—Ill-defined disorder—Temozolomide—melanoma	0.00118	0.00603	CcSEcCtD
Spironolactone—Leukopenia—Carmustine—melanoma	0.00118	0.00602	CcSEcCtD
Spironolactone—Malaise—Temozolomide—melanoma	0.00115	0.00586	CcSEcCtD
Spironolactone—Leukopenia—Temozolomide—melanoma	0.00114	0.00582	CcSEcCtD
Spironolactone—Thrombocytopenia—Dactinomycin—melanoma	0.00113	0.00574	CcSEcCtD
Spironolactone—Confusional state—Carmustine—melanoma	0.00109	0.00554	CcSEcCtD
Spironolactone—Stevens-Johnson syndrome—Docetaxel—melanoma	0.00108	0.00548	CcSEcCtD
Spironolactone—Discomfort—Temozolomide—melanoma	0.00107	0.00547	CcSEcCtD
Spironolactone—Renal failure—Docetaxel—melanoma	0.00107	0.00544	CcSEcCtD
Spironolactone—Thrombocytopenia—Carmustine—melanoma	0.00106	0.00538	CcSEcCtD
Spironolactone—Confusional state—Temozolomide—melanoma	0.00105	0.00535	CcSEcCtD
Spironolactone—Anaphylactic shock—Temozolomide—melanoma	0.00104	0.00531	CcSEcCtD
Spironolactone—Thrombocytopenia—Temozolomide—melanoma	0.00102	0.00519	CcSEcCtD
Spironolactone—Feeling abnormal—Bleomycin—melanoma	0.00102	0.00518	CcSEcCtD
Spironolactone—Agranulocytosis—Docetaxel—melanoma	0.00101	0.00516	CcSEcCtD
Spironolactone—Progesterone—CYP17A1—melanoma	0.00101	0.145	CrCbGaD
Spironolactone—Urticaria—Bleomycin—melanoma	0.000981	0.005	CcSEcCtD
Spironolactone—Body temperature increased—Bleomycin—melanoma	0.000976	0.00497	CcSEcCtD
Spironolactone—Somnolence—Carmustine—melanoma	0.000958	0.00488	CcSEcCtD
Spironolactone—Feeling abnormal—Dactinomycin—melanoma	0.000949	0.00483	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Carmustine—melanoma	0.00093	0.00474	CcSEcCtD
Spironolactone—Somnolence—Temozolomide—melanoma	0.000926	0.00472	CcSEcCtD
Spironolactone—Erythema multiforme—Docetaxel—melanoma	0.000922	0.0047	CcSEcCtD
Spironolactone—Body temperature increased—Dactinomycin—melanoma	0.00091	0.00464	CcSEcCtD
Spironolactone—Hypersensitivity—Bleomycin—melanoma	0.00091	0.00463	CcSEcCtD
Spironolactone—Gastrointestinal disorder—Temozolomide—melanoma	0.000899	0.00458	CcSEcCtD
Spironolactone—Feeling abnormal—Carmustine—melanoma	0.000888	0.00452	CcSEcCtD
Spironolactone—Pruritus—Bleomycin—melanoma	0.000874	0.00445	CcSEcCtD
Spironolactone—Alopecia—Docetaxel—melanoma	0.000861	0.00439	CcSEcCtD
Spironolactone—Feeling abnormal—Temozolomide—melanoma	0.000858	0.00437	CcSEcCtD
Spironolactone—Body temperature increased—Carmustine—melanoma	0.000852	0.00434	CcSEcCtD
Spironolactone—Hypersensitivity—Dactinomycin—melanoma	0.000848	0.00432	CcSEcCtD
Spironolactone—Urticaria—Temozolomide—melanoma	0.000827	0.00421	CcSEcCtD
Spironolactone—Body temperature increased—Temozolomide—melanoma	0.000823	0.00419	CcSEcCtD
Spironolactone—Muscle spasms—Docetaxel—melanoma	0.000816	0.00416	CcSEcCtD
Spironolactone—Hypersensitivity—Carmustine—melanoma	0.000794	0.00404	CcSEcCtD
Spironolactone—Diarrhoea—Dactinomycin—melanoma	0.000788	0.00401	CcSEcCtD
Spironolactone—Vomiting—Bleomycin—melanoma	0.000785	0.004	CcSEcCtD
Spironolactone—Rash—Bleomycin—melanoma	0.000778	0.00397	CcSEcCtD
Spironolactone—Dermatitis—Bleomycin—melanoma	0.000778	0.00396	CcSEcCtD
Spironolactone—Hypersensitivity—Temozolomide—melanoma	0.000767	0.00391	CcSEcCtD
Spironolactone—Leukopenia—Docetaxel—melanoma	0.00076	0.00387	CcSEcCtD
Spironolactone—Diarrhoea—Carmustine—melanoma	0.000737	0.00376	CcSEcCtD
Spironolactone—Pruritus—Temozolomide—melanoma	0.000737	0.00375	CcSEcCtD
Spironolactone—Nausea—Bleomycin—melanoma	0.000733	0.00374	CcSEcCtD
Spironolactone—Vomiting—Dactinomycin—melanoma	0.000732	0.00373	CcSEcCtD
Spironolactone—Rash—Dactinomycin—melanoma	0.000726	0.0037	CcSEcCtD
Spironolactone—SHBG—hindlimb—melanoma	0.000724	0.22	CbGeAlD
Spironolactone—Dizziness—Carmustine—melanoma	0.000713	0.00363	CcSEcCtD
Spironolactone—Diarrhoea—Temozolomide—melanoma	0.000713	0.00363	CcSEcCtD
Spironolactone—Progesterone—CYP1B1—melanoma	0.000702	0.101	CrCbGaD
Spironolactone—Confusional state—Docetaxel—melanoma	0.000698	0.00356	CcSEcCtD
Spironolactone—Anaphylactic shock—Docetaxel—melanoma	0.000693	0.00353	CcSEcCtD
Spironolactone—Dizziness—Temozolomide—melanoma	0.000689	0.00351	CcSEcCtD
Spironolactone—Vomiting—Carmustine—melanoma	0.000685	0.00349	CcSEcCtD
Spironolactone—Nausea—Dactinomycin—melanoma	0.000684	0.00348	CcSEcCtD
Spironolactone—Rash—Carmustine—melanoma	0.00068	0.00346	CcSEcCtD
Spironolactone—Dermatitis—Carmustine—melanoma	0.000679	0.00346	CcSEcCtD
Spironolactone—Thrombocytopenia—Docetaxel—melanoma	0.000678	0.00345	CcSEcCtD
Spironolactone—Headache—Carmustine—melanoma	0.000675	0.00344	CcSEcCtD
Spironolactone—Testosterone—CYP1B1—melanoma	0.000663	0.0951	CrCbGaD
Spironolactone—Vomiting—Temozolomide—melanoma	0.000662	0.00337	CcSEcCtD
Spironolactone—Rash—Temozolomide—melanoma	0.000657	0.00335	CcSEcCtD
Spironolactone—Dermatitis—Temozolomide—melanoma	0.000656	0.00334	CcSEcCtD
Spironolactone—Headache—Temozolomide—melanoma	0.000652	0.00332	CcSEcCtD
Spironolactone—Nausea—Carmustine—melanoma	0.00064	0.00326	CcSEcCtD
Spironolactone—Nausea—Temozolomide—melanoma	0.000619	0.00315	CcSEcCtD
Spironolactone—Somnolence—Docetaxel—melanoma	0.000616	0.00314	CcSEcCtD
Spironolactone—Drospirenone—PTGS2—melanoma	0.000615	0.0881	CrCbGaD
Spironolactone—Megestrol acetate—ABCB1—melanoma	0.000598	0.0858	CrCbGaD
Spironolactone—Gastrointestinal disorder—Docetaxel—melanoma	0.000598	0.00305	CcSEcCtD
Spironolactone—Feeling abnormal—Docetaxel—melanoma	0.000571	0.00291	CcSEcCtD
Spironolactone—Body temperature increased—Docetaxel—melanoma	0.000548	0.00279	CcSEcCtD
Spironolactone—Hypersensitivity—Docetaxel—melanoma	0.00051	0.0026	CcSEcCtD
Spironolactone—Pruritus—Docetaxel—melanoma	0.00049	0.0025	CcSEcCtD
Spironolactone—Diarrhoea—Docetaxel—melanoma	0.000474	0.00241	CcSEcCtD
Spironolactone—Dizziness—Docetaxel—melanoma	0.000458	0.00233	CcSEcCtD
Spironolactone—Vomiting—Docetaxel—melanoma	0.00044	0.00224	CcSEcCtD
Spironolactone—Rash—Docetaxel—melanoma	0.000437	0.00222	CcSEcCtD
Spironolactone—Dermatitis—Docetaxel—melanoma	0.000436	0.00222	CcSEcCtD
Spironolactone—Headache—Docetaxel—melanoma	0.000434	0.00221	CcSEcCtD
Spironolactone—Nausea—Docetaxel—melanoma	0.000411	0.0021	CcSEcCtD
Spironolactone—Methyltestosterone—ALB—melanoma	0.000344	0.0493	CrCbGaD
Spironolactone—PGR—blood vessel—melanoma	0.000311	0.0945	CbGeAlD
Spironolactone—SHBG—neck—melanoma	0.000247	0.075	CbGeAlD
Spironolactone—Hydrocortisone—ABCB1—melanoma	0.000247	0.0354	CrCbGaD
Spironolactone—Progesterone—ABCB1—melanoma	0.000201	0.0289	CrCbGaD
Spironolactone—Testosterone—ALB—melanoma	0.000199	0.0286	CrCbGaD
Spironolactone—Testosterone—ABCB1—melanoma	0.00019	0.0273	CrCbGaD
Spironolactone—NR3C2—retina—melanoma	0.000177	0.0536	CbGeAlD
Spironolactone—CYP11B2—lymph node—melanoma	0.000161	0.0487	CbGeAlD
Spironolactone—NR3C2—mammalian vulva—melanoma	0.000141	0.0429	CbGeAlD
Spironolactone—NR3C1—neck—melanoma	0.000129	0.039	CbGeAlD
Spironolactone—AR—skin of body—melanoma	0.000115	0.0348	CbGeAlD
Spironolactone—AR—mammalian vulva—melanoma	0.000105	0.0318	CbGeAlD
Spironolactone—NR3C2—head—melanoma	0.000101	0.0307	CbGeAlD
Spironolactone—ABCB1—blood vessel—melanoma	9.62e-05	0.0292	CbGeAlD
Spironolactone—NR3C1—eye—melanoma	9.56e-05	0.029	CbGeAlD
Spironolactone—PGR—head—melanoma	9.41e-05	0.0285	CbGeAlD
Spironolactone—SLCO1A2—head—melanoma	8.67e-05	0.0263	CbGeAlD
Spironolactone—NR3C1—skin of body—melanoma	8.32e-05	0.0252	CbGeAlD
Spironolactone—NR3C1—mammalian vulva—melanoma	7.59e-05	0.023	CbGeAlD
Spironolactone—AR—head—melanoma	7.49e-05	0.0227	CbGeAlD
Spironolactone—NR3C2—lymph node—melanoma	7.09e-05	0.0215	CbGeAlD
Spironolactone—PGR—lymph node—melanoma	6.59e-05	0.02	CbGeAlD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	6.05e-05	0.00021	CbGpPWpGaD
Spironolactone—AR—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	6.01e-05	0.000209	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	5.98e-05	0.000208	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	5.88e-05	0.000205	CbGpPWpGaD
Spironolactone—NR3C1—SIDS Susceptibility Pathways—IL6—melanoma	5.81e-05	0.000202	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PLCB4—melanoma	5.8e-05	0.000202	CbGpPWpGaD
Spironolactone—ABCB1—HIF-1-alpha transcription factor network—AKT1—melanoma	5.73e-05	0.0002	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—PPARG—melanoma	5.73e-05	0.0002	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HDAC2—melanoma	5.71e-05	0.000199	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FOXO4—melanoma	5.71e-05	0.000199	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CXCR4—melanoma	5.71e-05	0.000199	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—FASN—melanoma	5.69e-05	0.000198	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	5.68e-05	0.000198	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PRKCA—melanoma	5.68e-05	0.000198	CbGpPWpGaD
Spironolactone—ABCC2—lymph node—melanoma	5.66e-05	0.0172	CbGeAlD
Spironolactone—PGR—Generic Transcription Pathway—MYC—melanoma	5.65e-05	0.000197	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—GNAQ—melanoma	5.65e-05	0.000197	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ERCC2—melanoma	5.63e-05	0.000196	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP17A1—melanoma	5.58e-05	0.000194	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	5.51e-05	0.000192	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC6A11—melanoma	5.45e-05	0.00019	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIP4K2A—melanoma	5.45e-05	0.00019	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	5.44e-05	0.000189	CbGpPWpGaD
Spironolactone—NR3C1—head—melanoma	5.43e-05	0.0165	CbGeAlD
Spironolactone—CYP11B2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.42e-05	0.000189	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	5.41e-05	0.000188	CbGpPWpGaD
Spironolactone—AR—Gene Expression—CDKN2B—melanoma	5.35e-05	0.000186	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SYK—melanoma	5.31e-05	0.000185	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—MTAP—melanoma	5.31e-05	0.000185	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GNA11—melanoma	5.27e-05	0.000184	CbGpPWpGaD
Spironolactone—AR—lymph node—melanoma	5.25e-05	0.0159	CbGeAlD
Spironolactone—AR—Gene Expression—VDR—melanoma	5.22e-05	0.000182	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ITGAV—melanoma	5.21e-05	0.000182	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKT3—melanoma	5.21e-05	0.000182	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NGFR—melanoma	5.21e-05	0.000182	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	5.19e-05	0.000181	CbGpPWpGaD
Spironolactone—SLCO1A2—Transmembrane transport of small molecules—ALB—melanoma	5.17e-05	0.00018	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CG—melanoma	5.16e-05	0.00018	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—FASN—melanoma	5.16e-05	0.00018	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	5.13e-05	0.000179	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—HDAC2—melanoma	5.08e-05	0.000177	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—SLC5A5—melanoma	5.08e-05	0.000177	CbGpPWpGaD
Spironolactone—ABCB1—retina—melanoma	5.07e-05	0.0154	CbGeAlD
Spironolactone—PGR—Gene Expression—NOTCH1—melanoma	5.06e-05	0.000176	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	5.06e-05	0.000176	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PLCB4—melanoma	5.05e-05	0.000176	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	4.99e-05	0.000174	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PPARG—melanoma	4.98e-05	0.000173	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—GNAQ—melanoma	4.9e-05	0.000171	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CD44—melanoma	4.9e-05	0.000171	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—melanoma	4.88e-05	0.00017	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SOCS1—melanoma	4.83e-05	0.000168	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—S100B—melanoma	4.82e-05	0.000168	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PRKCA—melanoma	4.81e-05	0.000167	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	4.8e-05	0.000167	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—PPARG—melanoma	4.77e-05	0.000166	CbGpPWpGaD
Spironolactone—AR—Gene Expression—ERCC2—melanoma	4.77e-05	0.000166	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	4.76e-05	0.000166	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC6A11—melanoma	4.75e-05	0.000165	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIP4K2A—melanoma	4.75e-05	0.000165	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—LUM—melanoma	4.73e-05	0.000165	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PHGDH—melanoma	4.73e-05	0.000165	CbGpPWpGaD
Spironolactone—ABCC2—Transmembrane transport of small molecules—ALB—melanoma	4.71e-05	0.000164	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—CYP1B1—melanoma	4.7e-05	0.000164	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.67e-05	0.000162	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—SLC5A5—melanoma	4.64e-05	0.000161	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—HPSE—melanoma	4.64e-05	0.000161	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—MTAP—melanoma	4.62e-05	0.000161	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	4.62e-05	0.000161	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ERBB4—melanoma	4.61e-05	0.00016	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—MAPK3—melanoma	4.59e-05	0.00016	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDKN2B—melanoma	4.57e-05	0.000159	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CUBN—melanoma	4.55e-05	0.000158	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CD—melanoma	4.54e-05	0.000158	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	4.53e-05	0.000158	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—ALB—melanoma	4.48e-05	0.000156	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—MYC—melanoma	4.47e-05	0.000156	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CG—melanoma	4.45e-05	0.000155	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CD86—melanoma	4.42e-05	0.000154	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	4.41e-05	0.000153	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SDHD—melanoma	4.4e-05	0.000153	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—BSG—melanoma	4.4e-05	0.000153	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CSPG4—melanoma	4.4e-05	0.000153	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EDN1—melanoma	4.38e-05	0.000153	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	4.36e-05	0.000152	CbGpPWpGaD
Spironolactone—AR—Generic Transcription Pathway—MYC—melanoma	4.31e-05	0.00015	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PPARG—melanoma	4.29e-05	0.000149	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CSF2—melanoma	4.28e-05	0.000149	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FGF1—melanoma	4.28e-05	0.000149	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	4.26e-05	0.000148	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GPAM—melanoma	4.26e-05	0.000148	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	4.25e-05	0.000148	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	4.23e-05	0.000147	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—E2F1—melanoma	4.19e-05	0.000146	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.15e-05	0.000144	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PDGFRA—melanoma	4.15e-05	0.000144	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PHGDH—melanoma	4.12e-05	0.000143	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—LUM—melanoma	4.12e-05	0.000143	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ITGB3—melanoma	4.11e-05	0.000143	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PRKCA—melanoma	4.11e-05	0.000143	CbGpPWpGaD
Spironolactone—ABCB1—mammalian vulva—melanoma	4.06e-05	0.0123	CbGeAlD
Spironolactone—NR3C1—Gene Expression—CDKN2B—melanoma	4.06e-05	0.000141	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—HPSE—melanoma	4.04e-05	0.000141	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—SPP1—melanoma	4.03e-05	0.00014	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAP2K2—melanoma	4.01e-05	0.00014	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CUBN—melanoma	3.97e-05	0.000138	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—VDR—melanoma	3.96e-05	0.000138	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CB—melanoma	3.96e-05	0.000138	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTGS2—melanoma	3.92e-05	0.000136	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CD—melanoma	3.91e-05	0.000136	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ABCB1—melanoma	3.87e-05	0.000135	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—ALB—melanoma	3.86e-05	0.000134	CbGpPWpGaD
Spironolactone—AR—Gene Expression—NOTCH1—melanoma	3.85e-05	0.000134	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	3.84e-05	0.000134	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SDHD—melanoma	3.83e-05	0.000133	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—BSG—melanoma	3.83e-05	0.000133	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CSPG4—melanoma	3.83e-05	0.000133	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TERT—melanoma	3.82e-05	0.000133	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—RAC1—melanoma	3.81e-05	0.000133	CbGpPWpGaD
Spironolactone—NR3C1—lymph node—melanoma	3.8e-05	0.0115	CbGeAlD
Spironolactone—ABCB1—Metabolism—GPAM—melanoma	3.71e-05	0.000129	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HIF1A—melanoma	3.65e-05	0.000127	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PRKCA—melanoma	3.65e-05	0.000127	CbGpPWpGaD
Spironolactone—AR—Gene Expression—PPARG—melanoma	3.64e-05	0.000127	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	3.63e-05	0.000126	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PLA2G6—melanoma	3.62e-05	0.000126	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—ERCC2—melanoma	3.62e-05	0.000126	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PRKCA—melanoma	3.56e-05	0.000124	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—melanoma	3.53e-05	0.000123	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ERCC2—melanoma	3.53e-05	0.000123	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KDR—melanoma	3.49e-05	0.000122	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	3.46e-05	0.00012	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	3.46e-05	0.00012	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PTEN—melanoma	3.42e-05	0.000119	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CB—melanoma	3.41e-05	0.000119	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTGS2—melanoma	3.38e-05	0.000118	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FN1—melanoma	3.36e-05	0.000117	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—melanoma	3.29e-05	0.000115	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NOTCH1—melanoma	3.29e-05	0.000114	CbGpPWpGaD
Spironolactone—NR3C1—Generic Transcription Pathway—MYC—melanoma	3.27e-05	0.000114	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	3.27e-05	0.000114	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—VCAN—melanoma	3.25e-05	0.000113	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CD80—melanoma	3.22e-05	0.000112	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CG—melanoma	3.22e-05	0.000112	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—APC—melanoma	3.22e-05	0.000112	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KIT—melanoma	3.22e-05	0.000112	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EGF—melanoma	3.18e-05	0.000111	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PLA2G6—melanoma	3.15e-05	0.00011	CbGpPWpGaD
Spironolactone—NR3C2—Gene Expression—AKT1—melanoma	3.1e-05	0.000108	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	3.08e-05	0.000107	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—BRAF—melanoma	3.02e-05	0.000105	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	3e-05	0.000104	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.97e-05	0.000103	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PTEN—melanoma	2.95e-05	0.000103	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IGF1—melanoma	2.94e-05	0.000103	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	2.93e-05	0.000102	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—NOTCH1—melanoma	2.92e-05	0.000102	CbGpPWpGaD
Spironolactone—ABCB1—head—melanoma	2.91e-05	0.00881	CbGeAlD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—melanoma	2.9e-05	0.000101	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAP2K1—melanoma	2.85e-05	9.91e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—VCAN—melanoma	2.83e-05	9.86e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CD—melanoma	2.83e-05	9.84e-05	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MAPK3—melanoma	2.8e-05	9.74e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CG—melanoma	2.79e-05	9.71e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—PPARG—melanoma	2.76e-05	9.61e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP17A1—melanoma	2.74e-05	9.55e-05	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—MYC—melanoma	2.72e-05	9.47e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—FGF2—melanoma	2.71e-05	9.42e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.71e-05	9.42e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PPARG—melanoma	2.69e-05	9.37e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	2.67e-05	9.3e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GNA11—melanoma	2.59e-05	9.02e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—FASN—melanoma	2.54e-05	8.83e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MDM2—melanoma	2.53e-05	8.82e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—ERBB2—melanoma	2.5e-05	8.69e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—SLC5A5—melanoma	2.49e-05	8.68e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CB—melanoma	2.46e-05	8.58e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CD—melanoma	2.45e-05	8.54e-05	CbGpPWpGaD
Spironolactone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.45e-05	8.53e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—ALB—melanoma	2.42e-05	8.43e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—PIK3CA—melanoma	2.41e-05	8.4e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—GNAQ—melanoma	2.41e-05	8.39e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CD44—melanoma	2.41e-05	8.39e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CYP17A1—melanoma	2.39e-05	8.32e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CXCL8—melanoma	2.37e-05	8.24e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.36e-05	8.21e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.34e-05	8.14e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDKN1B—melanoma	2.31e-05	8.05e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—CYP1B1—melanoma	2.31e-05	8.04e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CASP3—melanoma	2.27e-05	7.89e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL2—melanoma	2.26e-05	7.88e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GNA11—melanoma	2.26e-05	7.86e-05	CbGpPWpGaD
Spironolactone—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	2.21e-05	7.7e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—FASN—melanoma	2.21e-05	7.69e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CCND1—melanoma	2.21e-05	7.68e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CTNNB1—melanoma	2.18e-05	7.61e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—SLC5A5—melanoma	2.17e-05	7.56e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MMP9—melanoma	2.14e-05	7.46e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CB—melanoma	2.14e-05	7.44e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—CDKN1A—melanoma	2.13e-05	7.43e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MAPK3—melanoma	2.13e-05	7.42e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PTEN—melanoma	2.13e-05	7.41e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NFKB1—melanoma	2.12e-05	7.38e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTGS2—melanoma	2.12e-05	7.37e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—GNAQ—melanoma	2.1e-05	7.31e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—CD44—melanoma	2.1e-05	7.31e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—PIK3CA—melanoma	2.08e-05	7.23e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—MYC—melanoma	2.07e-05	7.22e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.04e-05	7.1e-05	CbGpPWpGaD
Spironolactone—ABCB1—lymph node—melanoma	2.03e-05	0.00617	CbGeAlD
Spironolactone—ABCB1—Metabolism—CYP1B1—melanoma	2.01e-05	7e-05	CbGpPWpGaD
Spironolactone—CYP11B2—Metabolism—AKT1—melanoma	1.97e-05	6.86e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—VEGFA—melanoma	1.92e-05	6.7e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—STAT3—melanoma	1.9e-05	6.63e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ABCB1—melanoma	1.9e-05	6.62e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—NRAS—melanoma	1.9e-05	6.61e-05	CbGpPWpGaD
Spironolactone—PGR—Gene Expression—AKT1—melanoma	1.89e-05	6.57e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PTEN—melanoma	1.85e-05	6.43e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAPK3—melanoma	1.82e-05	6.33e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MYC—melanoma	1.77e-05	6.16e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PRKCA—melanoma	1.75e-05	6.09e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ERCC2—melanoma	1.74e-05	6.04e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—MAPK1—melanoma	1.73e-05	6.03e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—EGFR—melanoma	1.73e-05	6.03e-05	CbGpPWpGaD
Spironolactone—CYP11B1—Metabolism—AKT1—melanoma	1.7e-05	5.91e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—KRAS—melanoma	1.64e-05	5.69e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MAPK3—melanoma	1.62e-05	5.63e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—MYC—melanoma	1.57e-05	5.48e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PRKCA—melanoma	1.52e-05	5.31e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ERCC2—melanoma	1.51e-05	5.26e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—PIK3CA—melanoma	1.5e-05	5.23e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—TP53—melanoma	1.45e-05	5.06e-05	CbGpPWpGaD
Spironolactone—AR—Gene Expression—AKT1—melanoma	1.44e-05	5.01e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.44e-05	5.01e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—HRAS—melanoma	1.39e-05	4.84e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CG—melanoma	1.37e-05	4.77e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—IL6—melanoma	1.33e-05	4.63e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PPARG—melanoma	1.32e-05	4.61e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—PIK3CA—melanoma	1.3e-05	4.54e-05	CbGpPWpGaD
Spironolactone—PGR—Signaling Pathways—AKT1—melanoma	1.23e-05	4.27e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CD—melanoma	1.21e-05	4.2e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CG—melanoma	1.19e-05	4.16e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—ALB—melanoma	1.19e-05	4.14e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PPARG—melanoma	1.15e-05	4.01e-05	CbGpPWpGaD
Spironolactone—NR3C1—Gene Expression—AKT1—melanoma	1.09e-05	3.8e-05	CbGpPWpGaD
Spironolactone—SLCO1A2—Metabolism—AKT1—melanoma	1.06e-05	3.71e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CB—melanoma	1.05e-05	3.66e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CD—melanoma	1.05e-05	3.65e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTGS2—melanoma	1.04e-05	3.62e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—ALB—melanoma	1.04e-05	3.61e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CB—melanoma	9.15e-06	3.19e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PTEN—melanoma	9.08e-06	3.16e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTGS2—melanoma	9.07e-06	3.16e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PTEN—melanoma	7.91e-06	2.75e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—PIK3CA—melanoma	6.4e-06	2.23e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—PIK3CA—melanoma	5.58e-06	1.94e-05	CbGpPWpGaD
Spironolactone—CYP2C8—Metabolism—AKT1—melanoma	5.23e-06	1.82e-05	CbGpPWpGaD
Spironolactone—ABCB1—Metabolism—AKT1—melanoma	4.56e-06	1.59e-05	CbGpPWpGaD
